Table II

Table II Summary of Sites by Stage, Race, and Sex Indiana, 1996
Site	Number* of Cases	Percent of Total Cases	SEER** Summary Stage at Diagnosis					Race			Sex
Site	Number* of Cases	Percent of Total Cases	In Situ	Local	Regional	Distant	Unstaged	White	Black	Other	Male	Female
All sites	26,180	100.0%	2,050	10,752	6,120	4,973	2,285	24,155	1,772	253	12,401	13,779
Oral cavity and pharynx	610	2.3%	19	259	271	29	32	548	56	6	402	208
Lip	55	0.2%	6	45	1	0	3	54	0	1	43	12
Tongue	130	0.5%	4	51	63	4	8	115	14	1	86	44
Major salivary glands	67	0.3%	0	40	21	2	4	65	2	0	32	35
Floor of mouth	45	0.2%	2	22	16	2	3	41	3	1	33	12
Gum and other mouth	127	0.5%	4	58	51	9	5	114	12	1	69	58
Nasopharynx	32	0.1%	0	7	21	3	1	29	2	1	23	9
Tonsil	63	0.2%	2	15	42	2	2	53	10	0	48	15
Oropharynx	18	0.1%	0	4	13	1	0	13	5	0	14	4
Hypopharynx	51	0.2%	1	12	30	5	3	44	6	1	41	10
Pharynx and other oral cavity	22	0.1%	0	5	13	1	3	20	2	0	13	9
Digestive system	4,807	18.4%	253	1,321	1,927	973	333	4,423	359	25	2,501	2,306
Esophagus	238	0.9%	2	62	73	67	34	219	17	2	190	48
Stomach	295	1.1%	3	55	118	84	35	264	27	4	163	132
Small intestine	74	0.3%	2	20	32	15	5	63	11	0	35	39
Colon excluding rectum	2,414	9.2%	165	734	1,034	392	89	2,220	187	7	1,175	1,239
Rectum and rectosigmoid	887	3.4%	70	289	366	117	45	829	52	6	496	391
Anus, anal canal, and anorectum	60	0.2%	5	29	15	6	5	59	1	0	19	41
Liver and intrahepatic bile duct	159	0.6%	0	55	34	33	37	147	9	3	98	61
Gallbladder	55	0.2%	3	14	20	15	3	53	2	0	15	40
Other biliary	69	0.3%	0	14	31	10	14	66	3	0	44	25
Pancreas	492	1.9%	3	38	196	206	49	445	44	3	243	249
Retroperitoneum	24	0.1%	0	7	4	6	7	23	1	0	12	12
Peritoneum	29	0.1%	0	2	4	17	6	24	5	0	5	24
Other digestive organs	11	0.0%	0	2	0	5	4	11	0	0	6	5
Respiratory system	4,554	17.4%	20	1,100	1,293	1,682	459	4,228	303	23	2,846	1,708
Nasal cavity, ear, and sinuses	26	0.1%	0	7	13	6	0	25	1	0	17	9
Larynx	329	1.3%	17	197	82	14	19	304	25	0	261	68
Lung and bronchus	4,154	15.9%	3	890	1,185	1,655	421	3,857	274	23	2,536	1,618
Trachea, pleura, and other respiratory organs	45	0.2%	0	6	13	7	19	42	3	0	32	13
Bones and joints	42	0.2%	0	17	12	4	9	37	5	0	24	18
Soft tissue (including heart)	142	0.5%	0	77	27	24	14	128	12	2	94	48
Skin (including basal and squamous)	886	3.4%	147	589	42	57	51	841	15	30	506	380
Melanoma of the skin	767	2.9%	145	522	36	21	43	738	3	26	433	334
Other non-epithelial skin cancers	119	0.5%	2	67	6	36	8	103	12	4	73	46
Breast	4,372	16.7%	583	2,379	1,129	175	106	4,062	269	41	23	4,349
Female genital system	2,471	9.4%	763	977	301	340	90	2,281	160	30	0	2,471
Cervix uteri	918	3.5%	621	177	86	21	13	817	79	22	0	918
Corpus uteri	841	3.2%	31	607	116	54	33	797	41	3	0	841
Uterus, NOS	14	0.1%	0	4	4	2	4	11	2	1	0	14
Ovary	471	1.8%	0	124	69	249	29	451	20	0	0	471
Vagina	30	0.1%	10	9	5	3	3	27	3	0	0	30
Vulva	184	0.7%	101	52	19	5	7	167	13	4	0	184
Other female genital organs	13	0.0%	0	4	2	6	1	11	2	0	0	13
Male genital system	3,023	11.5%	18	2,100	428	220	257	2,669	302	52	3,023	0
Prostate gland	2,849	10.9%	10	1,992	400	197	250	2,503	299	47	2,849	0
Testis	137	0.5%	0	85	24	22	6	133	0	4	137	0
Penis	33	0.1%	8	19	4	1	1	29	3	1	33	0
Other male genital organs	4	0.0%	0	4	0	0	0	4	0	0	4	0
Urinary system	1,940	7.4%	247	1,131	271	188	103	1,838	92	10	1,322	618
Urinary bladder	1,150	4.4%	233	695	124	32	66	1,107	36	7	832	318
Kidney and renal pelvis	729	2.8%	7	398	138	152	34	673	53	3	453	276
Ureter	42	0.2%	6	29	3	2	2	39	3	0	26	16
Other urinary organs	19	0.1%	1	9	6	2	1	19	0	0	11	8
Eye and orbit	40	0.2%	0	32	2	1	5	36	1	3	16	24
Brain and other nervous system	377	1.4%	0	244	75	8	50	356	19	2	213	164
Brain	353	1.3%	0	232	75	5	41	336	15	2	206	147
Other nervous system	24	0.1%	0	12	0	3	9	20	4	0	7	17
Endocrine system	307	1.2%	0	199	72	23	13	287	14	6	83	224
Thyroid gland	277	1.1%	0	188	64	15	10	260	11	6	67	210
Other endocrine (including thymus)	30	0.1%	0	11	8	8	3	27	3	0	16	14
Lymphoma	1,181	4.5%	0	318	269	428	166	1,108	62	11	607	574
Hodgkin’s disease	152	0.6%	0	31	60	37	24	143	8	1	85	67
Non-Hodgkin’s lymphoma	1,029	3.9%	0	287	209	391	142	965	54	10	522	507
Multiple myeloma	244	0.9%	0	6	0	237	1	212	31	1	131	113
Leukemia	571	2.2%	0	0	0	571	0	532	32	7	316	255
Acute lymphocytic	69	0.3%	0	0	0	69	0	65	3	1	34	35
Chronic lymphocytic	159	0.6%	0	0	0	159	0	148	8	3	93	66
Acute myeloid	181	0.7%	0	0	0	181	0	169	11	1	91	90
Chronic myeloid	79	0.3%	0	0	0	79	0	73	4	2	47	32
Other leukemias	83	0.3%	0	0	0	83	0	77	6	0	51	32
Other, ill-defined, and unknown sites	613	2.3%	0	3	1	13	596	569	40	4	294	319
* Please note that these totals will not match those in Table I - 0 as these numbers include all in situ cases as well as basal and squamous skin cell cancers, and cases of unspecified age. ** Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. _________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001